Inventor

CAMPBELL ANN-MARIE

US59 patents

⚠️ This page may combine multiple inventors who share the name “CAMPBELL ANN-MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CAMPBELL ANN-MARIE

FORMA THERAPEUTICS INC

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

VALO EARLY DISCOVERY INC

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

FORMA TM2 INC

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

BAYER PHARMACEUTICALS CORP

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists

Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists

VALO HEALTH INC

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

SMITHKLINE BEECHAM CORP

Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents

CARA THERAPEUTICS INC

Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazines as cannabinoid receptor agonists for the treatment of pain

HENTEMANN MARTIN

Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

BAYER IP GMBH

Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

BAYER AG

Sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists